Merck

Showing 15 posts of 363 posts found.

Merck KGaA’s sales climb but key drugs fall

May 19, 2015
Sales and Marketing Erbitux, Merck, Merck KGaA, Q1, Rebif

Merck KGaA encountered an uneven start to 2015, with robust sales in the first quarter offset by declines in key …

Merck KGaA reveals ASCO plans

May 15, 2015
Sales and Marketing ASCO, Merck, Merck KGaA, Merck Serono, avelumab

Merck KGaA is the latest company to announce its slate for this year’s ASCO conference, and like other firms it …

Merck image

Merck to test Keytruda combinations

May 8, 2015
Sales and Marketing BMS, Daiichi Sankyo, Merck, Plexxikon, keytruda, pembrolizumab

Merck will be teaming up with Daiichi Sankyo’s subsidiary Plexxikon to investigate immunotherapy combinations in cancer. A collaborative clinical trial …

app image

New app can aid tropical disease treatment

May 8, 2015
Medical Communications, Sales and Marketing Merck, app, smartphone, tropical diseases

A new smartphone app is able to automatically detect parasites in the blood and may mark a fundamental shift in …

Merck image

Merck sales fall in Q1 despite new product lifts

April 29, 2015
Sales and Marketing Merck, Q1, Remicade

Merck’s sales were down in the first quarter of 2015 thanks to its consumer care divestment and increasing competition for …

GSK image

GSK shingles vaccine performs

April 29, 2015
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, HZ/su, Merck, zostovax

GlaxoSmithKline’s HZ/su vaccine candidate for the prevention of shingles has demonstrated promising benefits across all age groups in a late-stage …

Merck image

Conference round-up: companies go big on hepatitis C at EASL

April 29, 2015
Sales and Marketing Bristol-Myers Squibb, EASL, Merck, daclatasvir, daklinza

Big pharma names posted favourable results for hepatitis C treatments as they jostled for position as market leaders at the …

Opdivo

EMA approves BMS’ Opdivo for advanced skin cancer

April 27, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, EMA, Merck, Yervoy, ipilimumab, keytruda, melanoma, nivolumab, opdivo, pembrolizumab, skin cancer

Bristol-Myers Squibb has earned a recommendation from the EMA for its cancer immunotherapy treatment Opdivo as a monotherapy for patients …

jeroen_tonnaer

Cristal Therapeutics hires chief business officer from Merck

April 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cristal Therapeutics, Jeroen Tonnaer, Merck

Jeroen Tonnaer has been named as the new chief business officer responsible for Cristal Therapeutics’ business development, partnering and licensing …

alise_reicin

Merck Serono gains head of global clinical development

April 17, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alise Reicin, Merck, Merck Serono

Merck Serono, the biopharma business of Merck, has appointed Dr Alise Reicin as senior vice president and head of its …

udit_batra

Merck hires life sciences business head

April 15, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Sigma-Aldrich, udit batra

Merck has confirmed that the current chief executive and president of Merck Millipore Dr Udit Batra has been appointed to lead …

xalkori

Merck and Pfizer to co-promote cancer drug

April 9, 2015
Research and Development, Sales and Marketing Cancer, Merck, Merck KGaA, NSCLC, Pfizer, Xalkori, non-small cell lung cancer, oncology

Merck KgaA and Pfizer have agreed to co-promote the latter’s lung cancer treatment Xalkori, and form a new alliance that …

Merck image

Merck Ebola vaccine safe and effective in latest trials

April 2, 2015
Research and Development, Sales and Marketing Ebola, Merck, National Institutes of Health, VSV-ZEBOV, Vaccine, Walter Reed Army Institute of Research, newlink

Merck and NewLink’s experimental Ebola vaccine has been found to be safe and effective in a new trial in the …

Merck image

Merck lines up early-stage Keytruda combo trial

April 1, 2015
Research and Development, Sales and Marketing Cancer, Merck, entinostat, keytruda, pd1, pembrolizumab, syndax

Merck is planning for Keytruda’s future by launching early-stage trials of the drug in combination with an investigational treatment from …

Merck Serono image

Merck Serono in $826m immuno-oncology deal

March 31, 2015
Research and Development, Sales and Marketing Intrexon, Merck, Merck Serono, T cell, biopharma, cart, immuno-oncology, t-cell

Merck Serono has announced a significant deal with Intrexon to develop and bring new cancer treatments to market. The German …

The Gateway to Local Adoption Series

Latest content